Chemoinformaics analysis of N-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-9-METHYLDECANAMIDE
Molecular Weight | 321.461 | nRot | 11 |
Heavy Atom Molecular Weight | 290.213 | nRig | 1 |
Exact Molecular Weight | 321.23 | nRing | 1 |
Solubility: LogS | -1.921 | nHRing | 0 |
Solubility: LogP | 2.264 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 55.9066 |
nHD | 2 | BPOL | 34.2734 |
QED | 0.544 |
Synth | 1.841 |
Natural Product Likeliness | -0.204 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.015 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.212 |
MDCK | 0.0000376 |
BBB | 0.994 |
PPB | 0.624577 |
VDSS | 0.803 |
FU | 0.486084 |
CYP1A2-inh | 0.954 |
CYP1A2-sub | 0.323 |
CYP2c19-inh | 0.334 |
CYP2c19-sub | 0.676 |
CYP2c9-inh | 0.334 |
CYP2c9-sub | 0.698 |
CYP2d6-inh | 0.028 |
CYP2d6-sub | 0.066 |
CYP3a4-inh | 0.017 |
CYP3a4-sub | 0.242 |
CL | 11.343 |
T12 | 0.877 |
hERG | 0.008 |
Ames | 0.012 |
ROA | 0.027 |
SkinSen | 0.585 |
Carcinogencity | 0.193 |
EI | 0.988 |
Respiratory | 0.05 |
NR-Aromatase | 0.004 |
Antiviral | Yes |
Prediction | 0.696267 |